Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
102.00    2.10 (2.10%)
Bid:
101.00
Ask:
102.00
Spread: 1.00 (0.99%)
Market Cap: £620.36m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Dividend Declaration

5 Jul 2016 18:33

BACIT LIMITED - Dividend Declaration

BACIT LIMITED - Dividend Declaration

PR Newswire

London, July 5

BACIT Limited (the "Company")

(a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 55514)

2016 Dividend5 July 2016

The Board of the Company is pleased to announce a dividend equivalent to 2.20 pence per ordinary share for the year ended 31 March 2016 (the “2016 Dividend”). The 2016 Dividend will be paid on 19 August 2016 to holders of ordinary shares recorded on the register as at the close of business on 15 July 2016.

The Board has determined that the 2016 Dividend will be paid to the Qualifying Shareholders (as defined below) in the form of new ordinary shares unless those shareholders elect to receive the dividend in cash instead. The number of new shares that each Qualifying Shareholder will receive in payment of the 2016 Dividend will be determined by multiplying the number of existing shares held by the shareholder on the record date by the cash equivalent amount of the 2016 Dividend per share and dividing the resulting number by the net asset value per share of the Company as at 30 June 2016, and then rounding the result down to the nearest whole number. Fractions of new shares will not be issued and cash that otherwise would have been applied by the Company in paying up those fractions will be retained by the Company.

A “Qualifying Shareholder” is a shareholder who is not located in, or with a registered address in, or a citizen of any of the United States, Australia, Canada, Japan, South Africa or any other jurisdiction in respect of which the offer of new shares would or may be unlawful.

Shareholders who are not Qualifying Shareholders will receive the 2016 Dividend in cash. In addition, Qualifying Shareholders can elect to receive the 2016 Dividend in cash. A circular and form of election will be sent to shareholders during the week commencing 11 July 2016. Qualifying Shareholders who wish to receive the 2016 Dividend in cash should complete and return the form of election by 5.00pm on 3 August 2016.

Timetable:

Posting of Circular and Forms of ElectionExpected during the week commencing 11 July 2016
Shares quoted ex-dividend14 July 2016
Record date for dividend15 July 2016
Announcement of the 30 June 2016 NAVExpected during the week commencing 25 July 2016
Final date for receipt by the Receiving Agent of forms of election by Qualifying Shareholders who wish to receive cash5 p.m. on 3 August 2016
Dividend payment date19 August 2016
Shares to be issued and cash to be paid to shareholders who have opted for the cash dividend19 August 2016

In compliance with LR 9.6.1, copies of the following documents will be submitted to the National Storage Mechanism at the same time as they are issued and will be available for inspection at www.hemscott.com/nsm.do:

1.2016 Dividend Circular

2.Form of election

Enquiries:

Company website: www.bacitltd.com

Northern Trust International Fund Administration Services (Guernsey) Limited Martin Bourgaize

+44 (0) 1481 745819

meb16@ntrs.com

Page 2

Date   Source Headline
18th May 20217:00 amRNSNotice of Results
18th May 20217:00 amRNSFreeline reports Q1 results
12th May 20213:05 pmRNSAutolus to present additional data in AUTO1
12th May 20211:18 pmRNSDirector/PDMR Shareholding
11th May 202112:05 pmRNSAchilles reports Q1 financial results
7th May 20217:00 amRNSGyroscope Therapeutics update on proposed IPO
6th May 202112:05 pmRNSAutolus reports Q1 2021 Financial Results
4th May 20217:00 amRNSUpdate on Gyroscope proposed IPO in the US
19th Apr 202112:05 pmRNSAutolus appoints non-executive Chair
19th Apr 20217:00 amRNSGyroscope files registration statement
6th Apr 20214:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFreeline Reports Financial Results
31st Mar 20217:00 amRNSAchilles update on IPO
30th Mar 202112:04 pmRNSDirector/PDMR Shareholding
26th Mar 20217:06 amRNSGyroscope announces additional financing plans
26th Mar 20217:00 amRNSSyncona cornerstones $148m Series C in Gyroscope
25th Mar 202111:13 amRNSUpdate on Achilles’ proposed IPO
4th Mar 202112:10 pmRNSAutolus Reports Full Year 2020 Financial Results
2nd Mar 20217:00 amRNSAchilles files registration statement
12th Feb 20213:49 pmRNSGyroscope Announces Positive Interim Data
11th Feb 20217:00 amRNSNew commitment to Quell in largest ever Series A
11th Feb 20217:00 amRNSQuarterly and Business Update
10th Feb 20217:00 amRNSAutolus announces pricing of public offering
8th Feb 202112:09 pmRNSFreeline Updates Clinical Development Plan
5th Feb 20217:00 amRNSAchilles announces additional financing plans
5th Feb 20217:00 amRNSAchilles data and safety committee review
6th Jan 20217:00 amRNSAutolus Business Outlook
21st Dec 20207:00 amRNSVirginia Holmes Appointed Non-Executive Director
14th Dec 202012:05 pmRNSFreeline reports updated clinical data
7th Dec 20205:05 pmRNSAutolus presents additional data on AUTO3
7th Dec 20207:05 amRNSAutolus presents additional data on AUTO1
27th Nov 20204:35 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSSyncona founds Purespring with a £45m Series A
19th Nov 20207:00 amRNSHalf-year Report
5th Nov 202012:11 pmRNSAutolus reports Q3 2020 Financial Results
3rd Nov 20208:30 amRNSNotice of Results
2nd Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSFreeline H1 Results and Business Highlights
18th Sep 20208:10 amRNSAutolus presents additional data on AUTO3
14th Sep 20201:05 pmRNSSyncona expands cell therapy portfolio
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSQuarterly Update
7th Aug 20207:00 amRNSFreeline update on IPO
6th Aug 202012:10 pmRNSAutolus reports Q2 2020 Financial Results
3rd Aug 202011:30 amRNSUpdate on Freeline proposed IPO in the U.S.
28th Jul 202012:00 pmRNSResult of AGM
20th Jul 20207:00 amRNSFreeline files registration statement
13th Jul 20204:51 pmRNSFreeline publishes further data for FLT180a
9th Jul 20201:00 pmRNSIssue of shares pursuant to Incentive Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.